Entia Biosciences, Inc. – OTC:ERGO

Entia Biosciences stock price today

$0
-0.00
-50%
Financial Health
0
1
2
3
4
5
6
7
8
9

Entia Biosciences stock price monthly change

-100.00%
month

Entia Biosciences stock price quarterly change

-100.00%
quarter

Entia Biosciences stock price yearly change

-100.00%
year

Entia Biosciences key metrics

Market Cap
235.62K
Enterprise value
978.39K
P/E
N/A
EV/Sales
3.68
EV/EBITDA
-0.75
Price/Sales
0.03
Price/Book
N/A
PEG ratio
N/A
EPS
-0.05
Revenue
265.46K
EBITDA
-1.15M
Income
-1.47M
Revenue Q/Q
-32.76%
Revenue Y/Y
-23.47%
Profit margin
-525.78%
Oper. margin
-493.6%
Gross margin
65.53%
EBIT margin
-493.6%
EBITDA margin
-435.58%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Entia Biosciences stock price history

Entia Biosciences stock forecast

Entia Biosciences financial statements

Entia Biosciences, Inc. (OTC:ERGO): Profit margin
Mar 2016 79.2K -279.98K -353.52%
Jun 2016 98.42K -419.51K -426.23%
Sep 2016 41.85K -303.41K -724.91%
Dec 2016 45.98K -469.74K -1021.49%
Entia Biosciences, Inc. (OTC:ERGO): Debt to assets
Mar 2016 405772 1.43M 353.01%
Jun 2016 399798 1.78M 447.69%
Sep 2016 365827 2.00M 549.26%
Dec 2016 439141 2.40M 547.82%
Entia Biosciences, Inc. (OTC:ERGO): Cash Flow
Mar 2016 -99.19K -4.52K 79.58K
Jun 2016 -102.33K -2.58K 122.68K
Sep 2016 -73.61K 0 57.87K
Dec 2016 -439.95K 0 513.98K

Entia Biosciences alternative data

Entia Biosciences, Inc. (OTC:ERGO): Employee count
Aug 2023 6
Sep 2023 6
Oct 2023 6
Nov 2023 6
Dec 2023 6
Jan 2024 6
Feb 2024 6
Mar 2024 6
Apr 2024 6
May 2024 6
Jun 2024 6
Jul 2024 6

Entia Biosciences other data

  • What's the price of Entia Biosciences stock today?

    One share of Entia Biosciences stock can currently be purchased for approximately $0.

  • When is Entia Biosciences's next earnings date?

    Unfortunately, Entia Biosciences's (ERGO) next earnings date is currently unknown.

  • Does Entia Biosciences pay dividends?

    No, Entia Biosciences does not pay dividends.

  • How much money does Entia Biosciences make?

    Entia Biosciences has a market capitalization of 235.62K.

  • What is Entia Biosciences's stock symbol?

    Entia Biosciences, Inc. is traded on the OTC under the ticker symbol "ERGO".

  • What is Entia Biosciences's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Entia Biosciences?

    Shares of Entia Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Entia Biosciences have?

    As Jul 2024, Entia Biosciences employs 6 workers.

  • When Entia Biosciences went public?

    Entia Biosciences, Inc. is publicly traded company for more then 11 years since IPO on 15 Jul 2014.

  • What is Entia Biosciences's official website?

    The official website for Entia Biosciences is entiabio.com.

  • Where are Entia Biosciences's headquarters?

    Entia Biosciences is headquartered at 13565 SW Tualatin-Sherwood Road, Sherwood, OR.

  • How can i contact Entia Biosciences?

    Entia Biosciences's mailing address is 13565 SW Tualatin-Sherwood Road, Sherwood, OR and company can be reached via phone at +971 2280709.

Entia Biosciences company profile:

Entia Biosciences, Inc.

entiabio.com
Exchange:

OTC

Full time employees:

6

Industry:

Biotechnology

Sector:

Healthcare

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.

13565 SW Tualatin-Sherwood Road
Sherwood, OR 97140

:
ISIN: US29384E1047
CUSIP: 29384E104